← Back to All Filings

Hologic Exec Awarded 15k Shares in Performance Grant

Low SignificanceNovember 6, 2025 at 5:03:18 PM EST

HOLOGIC INC

$HOLX4CIK: 0000859737

Subscribe to track HOLX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Hologic Exec Awarded 15k Shares in Performance Grant

Company: Hologic Inc (HOLX) Form: 4 | Filed: 2025-11-06 Significance: Low

Insider: Verstreken Jan Title: Group President, International | Relationship: Officer

Transaction: • Type: Grant • Shares: 15,196 • Price: $0.00 • Value: $0 • Owned After: 119,010

Key Insight: A routine performance-based stock unit award to a group president, representing a negligible 0.007% of shares outstanding.

Market Context: This grant is part of standard executive compensation and does not signal a new market-moving event for the $16.49B company.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: HOLOGIC INC (HOLX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Hologic's Group President, International, received a routine performance-based stock grant of 15,196 shares as part of their compensation.
  • Market Impact: Negligible, as the grant represents a tiny fraction of shares outstanding and is not an open-market transaction.

Company Information

FieldValue
CompanyHOLOGIC INC
Ticker SymbolHOLX
CIK0000859737
IndustryX-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS

Insider Information

FieldValue
NameVerstreken Jan
CIK0001829658
Title/PositionGroup President, International
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-04
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved15,196
Price Per Share$0.00
Total Value$0
Shares Owned After119,010
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted15,196
% of Shares Outstanding0.007%
Post-Transaction Ownership119,010 shares (0.054% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction is immaterial against Hologic's $16.49 billion market capitalization.
  • Ownership Concentration: The insider's total holding of 0.054% is not a significant stake in the company.
  • Dilution Impact: The grant results in a negligible dilution of 0.007% for existing shareholders.
  • Transaction Significance: The transaction is considered routine executive compensation with low market significance, as it is an award and not an open-market purchase reflecting new insider sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a pre-planned, compensation-related stock grant, not an open-market transaction. It does not provide a signal regarding the insider's current view on the company's valuation.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open-market trade and will not affect trading volume.
  • Sentiment Indicator: Neutral. Stock grants are a standard part of executive compensation and do not typically influence market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing footnote indicates these are performance stock units (PSUs) for which performance criteria have been met. The shares are granted at no cost but remain subject to service-based vesting requirements.
Topics:#SECFiling#InsiderTrading#HOLX#Hologic#Form4#StockGrant#ExecutiveComp#Investing#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.